BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 35597036)

  • 1. Fuzhuan brick tea polysaccharides serve as a promising candidate for remodeling the gut microbiota from colitis subjects in vitro: Fermentation characteristic and anti-inflammatory activity.
    Chen G; Wang M; Zeng Z; Xie M; Xu W; Peng Y; Zhou W; Sun Y; Zeng X; Liu Z
    Food Chem; 2022 Oct; 391():133203. PubMed ID: 35597036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purified fraction of polysaccharides from Fuzhuan brick tea modulates the composition and metabolism of gut microbiota in anaerobic fermentation in vitro.
    Wang M; Chen G; Chen D; Ye H; Sun Y; Zeng X; Liu Z
    Int J Biol Macromol; 2019 Nov; 140():858-870. PubMed ID: 31446105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digestion under saliva, simulated gastric and small intestinal conditions and fermentation in vitro by human intestinal microbiota of polysaccharides from Fuzhuan brick tea.
    Chen G; Xie M; Wan P; Chen D; Ye H; Chen L; Zeng X; Liu Z
    Food Chem; 2018 Apr; 244():331-339. PubMed ID: 29120790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-inflammatory and gut microbiota modulatory effects of polysaccharides from Fuzhuan brick tea on colitis in mice induced by dextran sulfate sodium.
    Zeng Z; Xie Z; Chen G; Sun Y; Zeng X; Liu Z
    Food Funct; 2022 Jan; 13(2):649-663. PubMed ID: 34932051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of water- and alkali-extracted polysaccharides from Fuzhuan brick tea and their immunomodulatory effects
    Sun Y; Wang F; Liu Y; An Y; Chang D; Wang J; Xia F; Liu N; Chen X; Cao Y
    Food Funct; 2022 Jan; 13(2):806-824. PubMed ID: 34985061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polysaccharides from Fu brick tea ameliorate obesity by modulating gut microbiota and gut microbiota-related short chain fatty acid and amino acid metabolism.
    Zhu M; Ouyang J; Zhou F; Zhao C; Zhu W; Liu C; Huang P; Li J; Tang J; Zhang Z; Huang J; Wu M; Wang K; Liu Z
    J Nutr Biochem; 2023 Aug; 118():109356. PubMed ID: 37087075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fuzhuan Brick Tea Polysaccharides Attenuate Metabolic Syndrome in High-Fat Diet Induced Mice in Association with Modulation in the Gut Microbiota.
    Chen G; Xie M; Wan P; Chen D; Dai Z; Ye H; Hu B; Zeng X; Liu Z
    J Agric Food Chem; 2018 Mar; 66(11):2783-2795. PubMed ID: 29514453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiome-metabolome responses of Fuzhuan brick tea crude polysaccharides with immune-protective benefit in cyclophosphamide-induced immunosuppressive mice.
    Sun Y; Wang F; Liu Y; Liu S; An Y; Xue H; Wang J; Xia F; Chen X; Cao Y
    Food Res Int; 2022 Jul; 157():111370. PubMed ID: 35761628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular Polysaccharides of
    Xie Z; Zeng Z; Chen G; Dong W; Peng Y; Xu W; Sun Y; Zeng X; Liu Z
    J Agric Food Chem; 2023 May; 71(21):8023-8037. PubMed ID: 37203140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyphenols from Fu Brick Tea Reduce Obesity via Modulation of Gut Microbiota and Gut Microbiota-Related Intestinal Oxidative Stress and Barrier Function.
    Zhou F; Li YL; Zhang X; Wang KB; Huang JA; Liu ZH; Zhu MZ
    J Agric Food Chem; 2021 Dec; 69(48):14530-14543. PubMed ID: 34752089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of polysaccharides from Fuzhuan brick tea on immune function and gut microbiota of cyclophosphamide-treated mice.
    Bai Y; Zeng Z; Xie Z; Chen G; Chen D; Sun Y; Zeng X; Liu Z
    J Nutr Biochem; 2022 Mar; 101():108947. PubMed ID: 35017006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural Characterization and Immunostimulatory Activity of Heteropolysaccharides from Fuzhuan Brick Tea.
    Chen G; Bai Y; Zeng Z; Peng Y; Zhou W; Shen W; Zeng X; Liu Z
    J Agric Food Chem; 2021 Feb; 69(4):1368-1378. PubMed ID: 33481588
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Lu X; Jing Y; Zhang N; Cao Y
    J Agric Food Chem; 2022 Mar; 70(9):2957-2967. PubMed ID: 35201766
    [No Abstract]   [Full Text] [Related]  

  • 14. Crataegus pinnatifida polysaccharide alleviates colitis via modulation of gut microbiota and SCFAs metabolism.
    Guo C; Wang Y; Zhang S; Zhang X; Du Z; Li M; Ding K
    Int J Biol Macromol; 2021 Jun; 181():357-368. PubMed ID: 33774071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota from green tea polyphenol-dosed mice improves intestinal epithelial homeostasis and ameliorates experimental colitis.
    Wu Z; Huang S; Li T; Li N; Han D; Zhang B; Xu ZZ; Zhang S; Pang J; Wang S; Zhang G; Zhao J; Wang J
    Microbiome; 2021 Sep; 9(1):184. PubMed ID: 34493333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of chemical property, cytotoxicity and antioxidant activity in vitro and in vivo of polysaccharides from Fuzhuan brick teas.
    Chen G; Wang M; Xie M; Wan P; Chen D; Hu B; Ye H; Zeng X; Liu Z
    Int J Biol Macromol; 2018 Sep; 116():120-127. PubMed ID: 29730012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulatory activity of polysaccharides from the mycelium of Aspergillus cristatus, isolated from Fuzhuan brick tea, associated with the regulation of intestinal barrier function and gut microbiota.
    Xie Z; Bai Y; Chen G; Dong W; Peng Y; Xu W; Sun Y; Zeng X; Liu Z
    Food Res Int; 2022 Feb; 152():110901. PubMed ID: 35181077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compound polysaccharides ameliorate experimental colitis by modulating gut microbiota composition and function.
    Cai Y; Liu W; Lin Y; Zhang S; Zou B; Xiao D; Lin L; Zhong Y; Zheng H; Liao Q; Xie Z
    J Gastroenterol Hepatol; 2019 Sep; 34(9):1554-1562. PubMed ID: 30589960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of in vitro digestion and fermentation of Nostoc commune Vauch. polysaccharides on properties and gut microbiota.
    Li H; Liu S; Liu Y; Li W; Niu A; Ren P; Liu Y; Jiang C; Inam M; Guan L
    Carbohydr Polym; 2022 Apr; 281():119055. PubMed ID: 35074107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-chain fatty acids affect the development of inflammatory bowel disease through intestinal barrier, immunology, and microbiota: A promising therapy?
    Peng K; Xia S; Xiao S; Yu Q
    J Gastroenterol Hepatol; 2022 Sep; 37(9):1710-1718. PubMed ID: 35906780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.